Cascades (TSE:CAS - Get Free Report) had its target price boosted by equities researchers at CIBC from C$12.00 to C$13.00 in a research report issued on Wednesday,BayStreet.CA reports. CIBC's target price suggests a potential upside of 5.35% from the stock's current price.
Other equities analysts have also recently issued reports about the stock. TD Securities boosted their target price on shares of Cascades from C$12.00 to C$14.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Royal Bank of Canada raised their price objective on Cascades from C$12.00 to C$13.00 and gave the company a "sector perform" rating in a report on Friday, December 20th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of C$12.50.
Read Our Latest Report on CAS
Cascades Stock Performance
Shares of CAS stock traded up C$0.34 during trading hours on Wednesday, hitting C$12.34. The company's stock had a trading volume of 262,308 shares, compared to its average volume of 158,237. The stock has a market cap of C$1.25 billion, a PE ratio of -29.38, a price-to-earnings-growth ratio of 0.56 and a beta of 0.15. Cascades has a 12-month low of C$8.83 and a 12-month high of C$15.00. The company has a 50 day moving average of C$11.77 and a 200 day moving average of C$10.42. The company has a current ratio of 1.23, a quick ratio of 0.86 and a debt-to-equity ratio of 119.55.
Insider Activity
In related news, Senior Officer Luc Langevin sold 3,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of C$11.30, for a total value of C$33,900.00. Company insiders own 23.78% of the company's stock.
Cascades Company Profile
(
Get Free Report)
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
Read More
Before you consider Cascades, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cascades wasn't on the list.
While Cascades currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.